文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

输血相关循环超负荷的当代危险因素与结局

Contemporary Risk Factors and Outcomes of Transfusion-Associated Circulatory Overload.
PubMed 文献 · Crit Care Med · 2018-01-01
一句话结论限制性输血背景下输血相关循环超负荷发生率约每100例输血患者1例,为院内发病和死亡的独立危险因素。

该病例对照研究在4家三级医院前瞻性纳入200例经主动监测识别的输血相关循环超负荷患者,并按输血强度匹配405例对照。在2015年5月至2016年7月期间接受输血的20,845例患者(共输注128,263个血液成分)中,输血相关循环超负荷发生率为每100例输血患者1例。除心血管合并症外,多变量分析识别出急性肾损伤、急诊手术、输血前使用利尿剂和血浆输注(后者尤其在女性中)为独立预测因素。与匹配对照相比,输血相关循环超负荷患者更可能需要机械通气(71% vs 49%;p < 0.001)、输血后ICU和住院时间更长,且死亡率更高(21% vs 11%;p = 0.02),即使调整其他潜在混杂变量后仍如此。

要点

  • 在20,845例输血患者中,输血相关循环超负荷发生率为每100例输血患者1例。
  • 独立预测因素包括心血管合并症、急性肾损伤、急诊手术、输血前使用利尿剂和血浆输注,血浆输注尤其在女性中相关。
  • 与匹配对照相比,输血相关循环超负荷患者更需要机械通气(71% vs 49%;p < 0.001)。
  • 输血相关循环超负荷患者死亡率更高(21% vs 11%;p = 0.02),且输血后ICU和住院时间更长。
  • 作者认为需要进一步研究以减少高危患者的红细胞或血浆暴露。

适用人群与场景

  • 4家三级医院中接受输血的患者,输血相关循环超负荷病例经主动监测识别,对照按输血强度匹配。

诊断标准与关键阈值

  • 输血相关循环超负荷定义为输血后出现静水性肺水肿。

研究设计与关键结果

  • 研究类型为病例对照研究,纳入200例输血相关循环超负荷患者和405例按输血强度匹配的对照。
  • 2015年5月至2016年7月期间,20,845例输血患者共接受128,263个血液成分,输血相关循环超负荷发生率为每100例输血患者1例。
  • 多变量分析识别出的独立预测因素包括心血管合并症、急性肾损伤、急诊手术、输血前使用利尿剂和血浆输注,血浆输注尤其在女性中相关。
  • 与匹配对照相比,输血相关循环超负荷患者更需要机械通气(71% vs 49%;p < 0.001)。
  • 与匹配对照相比,输血相关循环超负荷患者输血后ICU和住院时间更长,死亡率更高(21% vs 11%;p = 0.02),即使调整其他潜在混杂变量后仍如此。

证据类型、等级与局限

  • 证据类型为病例对照研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,需要进一步研究以减少高危输血相关循环超负荷患者的红细胞或血浆暴露。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: Transfusion-associated circulatory overload is characterized by hydrostatic pulmonary edema following blood transfusion. Restrictive transfusion practice may affect the occurrence and severity of transfusion-associated circulatory overload in critically ill patients. We sought to examine contemporary risk factors and outcomes for transfusion-associated circulatory overload.

DESIGN: Case-control study.

SETTING: Four tertiary care hospitals.

PATIENTS: We prospectively enrolled 200 patients with transfusion-associated circulatory overload identified by active surveillance and 405 controls matched by transfusion intensity.

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: Among 20,845 transfused patients who received 128,263 blood components from May 2015 until July 2016, transfusion-associated circulatory overload incidence was one case per 100 transfused patients. In addition to cardiovascular comorbidities, multivariable analysis identified the following independent predictors of transfusion-associated circulatory overload: acute kidney injury, emergency surgery, pretransfusion diuretic use, and plasma transfusion-the latter especially in females. Compared with matched controls, transfusion-associated circulatory overload cases were more likely to require mechanical ventilation (71% vs 49%; p < 0.001), experienced longer intensive care and hospital lengths of stay following transfusion, and had higher mortality (21% vs 11%; p = 0.02) even after adjustment for other potentially confounding variables.

CONCLUSIONS: Despite restrictive transfusion practice, transfusion-associated circulatory overload remains a frequent complication of transfusion and is an independent risk factor for in-hospital morbidity and mortality. In addition to cardiovascular and renal risk factors, plasma transfusion was associated with transfusion-associated circulatory overload after controlling for other covariates. Additional research is needed to examine the benefit of reduced erythrocyte or plasma exposure in patients at high risk for transfusion-associated circulatory overload.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Roubinian NH, Hendrickson JE, Triulzi DJ, et al. Contemporary Risk Factors and Outcomes of Transfusion-Associated Circulatory Overload. Crit Care Med. 2018. PMID: 29300236. doi:10.1097/CCM.0000000000002948

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。